NCT02756247 2022-10-10A Clinical Trial of Buparlisib and Ibrutinib in LymphomaMemorial Sloan Kettering Cancer CenterPhase 1 Completed37 enrolled
NCT02049541 2022-06-30Study of BKM120 & Rituximab in Patients With Relapsed or Refractory Indolent B-Cell LymphomaOhio State University Comprehensive Cancer CenterPhase 1 Completed18 enrolled